Valion Bio, Inc. (VBIO)
1.17
-0.06
(-4.88%)
USD |
NASDAQ |
Oct 16, 16:00
1.14
-0.03
(-2.56%)
After-Hours: 20:00
Valion Bio Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2025 | -1.78K% |
| June 30, 2025 | |
| March 31, 2025 | |
| December 31, 2024 | -820.6% |
| September 30, 2024 | -1.14K% |
| June 30, 2024 | -904.3% |
| March 31, 2024 | -443.4% |
| December 31, 2023 | -628.3% |
| September 30, 2023 | -624.1% |
| June 30, 2023 | -1.32K% |
| March 31, 2023 | -562.8% |
| December 31, 2022 | -552.5% |
| Date | Value |
|---|---|
| September 30, 2022 | -541.7% |
| June 30, 2022 | -571.6% |
| March 31, 2022 | -523.4% |
| December 31, 2021 | -957.3% |
| September 30, 2021 | -837.5% |
| June 30, 2021 | -408.2% |
| March 31, 2021 | -419.8% |
| December 31, 2020 | -301.1% |
| September 30, 2020 | -384.8% |
| June 30, 2020 | -471.8% |
| March 31, 2020 | -821.3% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Outlook Therapeutics, Inc. | -233.6K% |
| Agenus, Inc. | -1.64% |
| Amgen, Inc. | 23.59% |
| Anika Therapeutics, Inc. | 10.15% |
| BioCryst Pharmaceuticals, Inc. | 35.92% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -176.8% |
| Return on Assets | -103.0% |
| Return on Invested Capital | -113.7% |
| Return on Net Operating Assets | -132.3% |